Refractory status epilepticus caused by Anti-NMDA receptor encephalitis that markedly improved following combination therapy with rituximab and cyclophosphamide

Internal Medicine

Volumn 54, Issue 2, 2015, Pages 209-213

  Kadoya, Masato ^a   Onoue, Hiroyuki ^a   Kadoya, Akiko ^a   Ikewaki, Katsunori ^a   Kaida, Kenichi ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Anti NMDA receptor antibody; Cyclophosphamide; Limbic encephalitis; Rituximab; Second line immunotherapy; Status epilepticus

Indexed keywords

CYCLOPHOSPHAMIDE; ETIRACETAM; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; LAMOTRIGINE; METHYLPREDNISOLONE; MIDAZOLAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; PHENOBARBITAL; PREDNISOLONE; PROPOFOL; RITUXIMAB; MONOCLONAL ANTIBODY;

ADULT; ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; CONSCIOUSNESS DISORDER; DRUG DOSE REDUCTION; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; FEMALE; FEVER; HEPATITIS C VIRUS; HUMAN; HYPERCAPNIA; HYPONATREMIA; HYPOVENTILATION; IMMUNOTHERAPY; LEUKOCYTOSIS; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEOCYTOSIS; ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; COMPLICATION; DRUG COMBINATION; ELECTROENCEPHALOGRAPHY; STATUS EPILEPTICUS;

ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MIDDLE AGED; STATUS EPILEPTICUS;

EID: 84921315095     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.54.2047     Document Type: Article

References (12)

1. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7: 1091-1098, 2008.
2. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and labolatory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10: 63-74, 2011.
3. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti- NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12: 157-165, 2013.
4. Johnson N, Henry C, Fessler AJ, Dalmau J. Anti-NMDA receptor encephalitis causing prolonged nonconvulsive status epilepticus. Neurology 75: 1480-1482, 2010.
5. Kirkpatrick MP, Clarke CD, Sonmezturk HH, Abou-Khalil B. Rhythmic delta activity represents a form of nonconvulsive status epilepticus in anti-NMDA receptor antibody encephalitis. Epilepsy Behav 20: 392-394, 2011.
6. Iizuka T, Sakai F, Ide T, et al. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology 70: 504-511, 2008.
7. Schmitt SE, Pargeon K, Frechette ES, et al. Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology 79: 1094-1100, 2012.
8. Ishiura H, Matsuda S, Higashihara M, et al. Response of anti- NMDA receptor encephalitis without tumor to immunotherapy including rituximab. Neurology 71: 1921-1923, 2008.
9. Ikeguchi R, Shibuya K, Akiyama S, et al. Rituximab used successfully in the treatment of anti-NMDA receptor encephalitis. Intern Med 51: 1585-1589, 2012.
10. Kashyape P, Taylor E, Ng J, Krishnakumar D, Kirkham F, Whitney A. Successful treatment of two paediatric cases of anti-NMDA receptor encephalitis with Cyclophosphamide: the need for early aggressive immunotherapy in tumour negative paediatric patients. Eur J Paediatr Neurol 16: 74-78, 2012.
11. Gabilondo I, Saiz A, Galan L, et al. Analysis of relapses in anti-NMDAR encephalitis. Neurology 77: 996-999, 2011.
12. Irani SR, Bera K, Waters P, et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133: 1655-1667, 2010.